Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)

CUSIP: 00972D105

Q3 2017 13F Holders as of 30 Sep 2017

Holder snapshot 7 signals
Share change
+2,938,463
Put/Call ratio
0%
SEC-reported price per share
$19.67
Number of holders
118
Value change
+$67,324,611
Number of buys
80
Open additional details 1 more signal available
Number of sells
37
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
270,093,163

Security key

00972D105

Report period

Q3 2017

Institutions

118

Top holders

10

Ownership snapshot

Top reported holders of AKBA - Akebia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
EAGLE ASSET MANAGEMENT INC
Disclosed value leader
EAGLE ASSET MANAGEMENT INC
Comparable rows
15/15
Latest evidence
30 Jun 2017
13F Lead comparable stake: 1.3% Showing 1-6 of 15 holder rows.

Quick read

EAGLE ASSET MANAGEMENT INC leads the comparable SEC ownership view at 1.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens EAGLE ASSET MANAGEMENT INC's linked filing trail.
Comparable ownership Top 5
EAGLE ASSET MANAGEMENT INC 1.3%
BlackRock Finance, Inc. 1%
Nantahala Capital Management, LLC 0.8%
Novo Holdings A/S 0.67%
VANGUARD GROUP INC 0.53%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
EAGLE ASSET MANAGEMENT INC
13F
Company
13F
1.3%
$50,664,000
3,525,685 shares
30 Jun 2017
BlackRock Finance, Inc.
13F
Company
13F
1%
$39,440,000
2,744,607 shares
30 Jun 2017
Nantahala Capital Management, LLC
13F
Company
13F
0.8%
$30,876,000
2,148,623 shares
30 Jun 2017
Novo Holdings A/S
13F
Company
13F
0.67%
$26,071,000
1,814,289 shares
30 Jun 2017
VANGUARD GROUP INC
13F
Company
13F
0.53%
$20,638,000
1,436,163 shares
30 Jun 2017
FIRST MANHATTAN CO. LLC.
13F
Company
13F
0.44%
$17,078,000
1,188,500 shares
30 Jun 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
118
Shares
30,165,358
Rows available
118
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
115
Q3 2017 holders
118
Holder diff
3
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 value Q3 2017 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .